Alta Fundamental Advisers LLC
- SEC CIK
- 0001641604
- Latest filing
- Aug 12, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by Alta Fundamental Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q2 2026 holdings
- Shares (Q2 2026)
- 404,529
- Value
- $16.6M
- % of portfolio
- 6.0%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 404,529 | $16.6M | 6.0% | −5,000−1.2% | Reduced | Holders |
| Q1 2026 | 409,529 | $12.5M | 4.9% | 00.0% | Unchanged | Holders |
| Q4 2025 | 409,529 | $14.7M | 6.9% | −65,520−13.8% | Reduced | Holders |
| Q3 2025 | 475,049 | $11.5M | 5.6% | −100,000−17.4% | Reduced | Holders |
| Q2 2025 | 575,049 | $8.48M | 4.6% | +240,580+71.9% | Added | Holders |
| Q1 2025 | 334,469 | $3.19M | 2.1% | −65,531−16.4% | Reduced | Holders |
| Q4 2024 | 400,000 | $4.97M | 1.8% | +75,000+23.1% | Added | Holders |
| Q3 2024 | 325,000 | $2.39M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 325,000 | $4.03M | 1.8% | +175,000+116.7% | Added | Holders |
| Q1 2024 | 150,000 | $2.54M | 1.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 150,000 | $1.78M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2023 | 150,000 | $2.67M | 1.6% | 00.0% | Unchanged | Holders |
| Q2 2023 | 150,000 | $2.73M | 1.5% | +150,000 | New | Holders |